nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—Pallor—Teniposide—lymphatic system cancer	0.0345	0.0345	CcSEcCtD
Apomorphine—Cardiac failure congestive—Fludarabine—lymphatic system cancer	0.0201	0.0201	CcSEcCtD
Apomorphine—Contusion—Mitoxantrone—lymphatic system cancer	0.0172	0.0172	CcSEcCtD
Apomorphine—Dehydration—Fludarabine—lymphatic system cancer	0.017	0.017	CcSEcCtD
Apomorphine—Injection site reaction—Carmustine—lymphatic system cancer	0.016	0.016	CcSEcCtD
Apomorphine—Sweating increased—Fludarabine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Apomorphine—Angina pectoris—Fludarabine—lymphatic system cancer	0.0154	0.0154	CcSEcCtD
Apomorphine—Pneumonia—Fludarabine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Apomorphine—Urinary tract infection—Fludarabine—lymphatic system cancer	0.0137	0.0137	CcSEcCtD
Apomorphine—Ecchymosis—Mitoxantrone—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Apomorphine—Flushing—Teniposide—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Apomorphine—Swelling—Carmustine—lymphatic system cancer	0.0132	0.0132	CcSEcCtD
Apomorphine—Swelling—Mitoxantrone—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Apomorphine—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.012	0.012	CcSEcCtD
Apomorphine—Pain in extremity—Vincristine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Apomorphine—Chest pain—Teniposide—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Apomorphine—Pneumonia—Bleomycin—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Apomorphine—Dehydration—Vincristine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Apomorphine—Confusional state—Teniposide—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Apomorphine—Oedema—Teniposide—lymphatic system cancer	0.0102	0.0102	CcSEcCtD
Apomorphine—Dehydration—Mitoxantrone—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Apomorphine—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00987	0.00987	CcSEcCtD
Apomorphine—Pruritus—Mechlorethamine—lymphatic system cancer	0.0098	0.0098	CcSEcCtD
Apomorphine—Hypotension—Teniposide—lymphatic system cancer	0.00954	0.00954	CcSEcCtD
Apomorphine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00948	0.00948	CcSEcCtD
Apomorphine—Arthralgia—Fludarabine—lymphatic system cancer	0.00936	0.00936	CcSEcCtD
Apomorphine—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00915	0.00915	CcSEcCtD
Apomorphine—Dyspnoea—Teniposide—lymphatic system cancer	0.0091	0.0091	CcSEcCtD
Apomorphine—Pneumonia—Carmustine—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Apomorphine—Confusional state—Fludarabine—lymphatic system cancer	0.00905	0.00905	CcSEcCtD
Apomorphine—Oedema—Fludarabine—lymphatic system cancer	0.00897	0.00897	CcSEcCtD
Apomorphine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00881	0.00881	CcSEcCtD
Apomorphine—Urinary tract infection—Carmustine—lymphatic system cancer	0.00875	0.00875	CcSEcCtD
Apomorphine—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00868	0.00868	CcSEcCtD
Apomorphine—Pneumonia—Vincristine—lymphatic system cancer	0.00865	0.00865	CcSEcCtD
Apomorphine—Flushing—Bleomycin—lymphatic system cancer	0.0086	0.0086	CcSEcCtD
Apomorphine—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00842	0.00842	CcSEcCtD
Apomorphine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00841	0.00841	CcSEcCtD
Apomorphine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00837	0.00837	CcSEcCtD
Apomorphine—Nausea—Mechlorethamine—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00818	0.00818	CcSEcCtD
Apomorphine—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00814	0.00814	CcSEcCtD
Apomorphine—Hallucination—Carmustine—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Apomorphine—Dyspnoea—Fludarabine—lymphatic system cancer	0.008	0.008	CcSEcCtD
Apomorphine—Fatigue—Fludarabine—lymphatic system cancer	0.00774	0.00774	CcSEcCtD
Apomorphine—Hallucination—Vincristine—lymphatic system cancer	0.00768	0.00768	CcSEcCtD
Apomorphine—Constipation—Fludarabine—lymphatic system cancer	0.00767	0.00767	CcSEcCtD
Apomorphine—Flushing—Carmustine—lymphatic system cancer	0.0075	0.0075	CcSEcCtD
Apomorphine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0074	0.0074	CcSEcCtD
Apomorphine—Asthenia—Teniposide—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Apomorphine—Pruritus—Teniposide—lymphatic system cancer	0.00722	0.00722	CcSEcCtD
Apomorphine—Mental disorder—Carmustine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Apomorphine—Diarrhoea—Teniposide—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Apomorphine—Chest pain—Bleomycin—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Apomorphine—Back pain—Carmustine—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Apomorphine—Mental disorder—Vincristine—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Apomorphine—Ecchymosis—Methotrexate—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Apomorphine—Confusional state—Bleomycin—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Apomorphine—Oedema—Bleomycin—lymphatic system cancer	0.00658	0.00658	CcSEcCtD
Apomorphine—Back pain—Vincristine—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Apomorphine—Vomiting—Teniposide—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Apomorphine—Asthenia—Fludarabine—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Apomorphine—Headache—Teniposide—lymphatic system cancer	0.0064	0.0064	CcSEcCtD
Apomorphine—Pruritus—Fludarabine—lymphatic system cancer	0.00635	0.00635	CcSEcCtD
Apomorphine—Back pain—Mitoxantrone—lymphatic system cancer	0.00633	0.00633	CcSEcCtD
Apomorphine—Hypotension—Bleomycin—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Apomorphine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Apomorphine—Nausea—Teniposide—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.006	0.006	CcSEcCtD
Apomorphine—Chest pain—Carmustine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Apomorphine—Anxiety—Carmustine—lymphatic system cancer	0.00597	0.00597	CcSEcCtD
Apomorphine—Dyspnoea—Bleomycin—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Apomorphine—Confusional state—Carmustine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Apomorphine—Oedema—Carmustine—lymphatic system cancer	0.00574	0.00574	CcSEcCtD
Apomorphine—Vomiting—Fludarabine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Apomorphine—Headache—Fludarabine—lymphatic system cancer	0.00562	0.00562	CcSEcCtD
Apomorphine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Apomorphine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Apomorphine—Anxiety—Mitoxantrone—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Apomorphine—Oedema—Vincristine—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Apomorphine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Apomorphine—Confusional state—Mitoxantrone—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Apomorphine—Hypotension—Carmustine—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Apomorphine—Oedema—Mitoxantrone—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Apomorphine—Nausea—Fludarabine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Apomorphine—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Apomorphine—Shock—Mitoxantrone—lymphatic system cancer	0.00525	0.00525	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00523	0.00523	CcSEcCtD
Apomorphine—Insomnia—Carmustine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Apomorphine—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00516	0.00516	CcSEcCtD
Apomorphine—Hypotension—Vincristine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Apomorphine—Dyspnoea—Carmustine—lymphatic system cancer	0.00512	0.00512	CcSEcCtD
Apomorphine—Somnolence—Carmustine—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.005	0.005	CcSEcCtD
Apomorphine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Apomorphine—Insomnia—Vincristine—lymphatic system cancer	0.00496	0.00496	CcSEcCtD
Apomorphine—Constipation—Carmustine—lymphatic system cancer	0.00491	0.00491	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Apomorphine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Apomorphine—Somnolence—Mitoxantrone—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Apomorphine—Feeling abnormal—Carmustine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Apomorphine—Fatigue—Vincristine—lymphatic system cancer	0.00473	0.00473	CcSEcCtD
Apomorphine—Asthenia—Bleomycin—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Apomorphine—Constipation—Vincristine—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Apomorphine—Pruritus—Bleomycin—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Apomorphine—Fatigue—Mitoxantrone—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Apomorphine—Constipation—Mitoxantrone—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Apomorphine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Apomorphine—Pneumonia—Methotrexate—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Apomorphine—Vomiting—Bleomycin—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Apomorphine—Drowsiness—Methotrexate—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Apomorphine—Asthenia—Carmustine—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Apomorphine—Asthenia—Vincristine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Apomorphine—Diarrhoea—Carmustine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Apomorphine—Nausea—Bleomycin—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Apomorphine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Apomorphine—Dizziness—Carmustine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Apomorphine—Diarrhoea—Vincristine—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Apomorphine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Apomorphine—Vomiting—Carmustine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Apomorphine—Dizziness—Vincristine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Apomorphine—Headache—Carmustine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Apomorphine—Vomiting—Vincristine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Apomorphine—Headache—Vincristine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Apomorphine—Nausea—Carmustine—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Apomorphine—Vomiting—Mitoxantrone—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Apomorphine—Headache—Mitoxantrone—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Apomorphine—Mental disorder—Methotrexate—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Apomorphine—Nausea—Vincristine—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Apomorphine—Nausea—Mitoxantrone—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Apomorphine—Back pain—Methotrexate—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Apomorphine—Arthralgia—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Apomorphine—Chest pain—Methotrexate—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Apomorphine—Confusional state—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Apomorphine—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Apomorphine—Hypotension—Methotrexate—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Apomorphine—Insomnia—Methotrexate—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Apomorphine—Dyspnoea—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Apomorphine—Somnolence—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Apomorphine—Fatigue—Methotrexate—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Apomorphine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Apomorphine—Asthenia—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Apomorphine—Pruritus—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Apomorphine—Diarrhoea—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Apomorphine—Dizziness—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Apomorphine—Vomiting—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Apomorphine—Headache—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Apomorphine—Nausea—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
